1. Home
  2. CTS vs NBTX Comparison

CTS vs NBTX Comparison

Compare CTS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CTS Corporation

CTS

CTS Corporation

HOLD

Current Price

$44.74

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$22.54

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTS
NBTX
Founded
1896
2003
Country
United States
France
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CTS
NBTX
Price
$44.74
$22.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
184.4K
49.5K
Earning Date
10-28-2025
09-30-2025
Dividend Yield
0.36%
N/A
EPS Growth
3.07
N/A
EPS
1.98
N/A
Revenue
$531,522,000.00
$11,930,711.00
Revenue This Year
$5.73
N/A
Revenue Next Year
$4.00
$136.64
P/E Ratio
$22.55
N/A
Revenue Growth
3.61
N/A
52 Week Low
$34.02
$2.82
52 Week High
$57.49
$30.35

Technical Indicators

Market Signals
Indicator
CTS
NBTX
Relative Strength Index (RSI) 59.56 57.62
Support Level $42.68 $20.83
Resistance Level $45.65 $22.05
Average True Range (ATR) 1.39 0.91
MACD 0.12 0.06
Stochastic Oscillator 79.09 78.81

Price Performance

Historical Comparison
CTS
NBTX

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: